Roche breast cancer drug gets U.S. pre-surgery approval
(Reuters) - U.S. health regulators expanded the approval of Roche Holding AG's breast cancer drug Perjeta and will now allow its use to help shrink tu...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/IgSW5RAsAn4/story01.htm
No comments:
Post a Comment